Tweets
- Tweets, current page.
- Tweets & replies
- Media
You blocked @PoojaBheda
Are you sure you want to view these Tweets? Viewing Tweets won't unblock @PoojaBheda
-
Pinned Tweet
Drug prices in China and Pharma is not so stingy with R&D after all -->https://www.linkedin.com/pulse/drug-prices-china-pharma-so-stringy-rd-after-all-pooja-bheda …
Thanks. Twitter will use this to make your timeline better. Undo -
The end of human doctors and a jump in drug approvals -->https://www.linkedin.com/pulse/end-human-doctors-jump-drug-approvals-pooja-bheda …
Thanks. Twitter will use this to make your timeline better. Undo -
Thanks. Twitter will use this to make your timeline better. Undo
-
Healthcare in Hand - An Overview of Mobile Health Startups -->https://www.linkedin.com/pulse/healthcare-hand-overview-mobile-health-startups-pooja-bheda …
Thanks. Twitter will use this to make your timeline better. Undo -
Q1 2017: Noteworthy Young Life Sciences Startups that Got Funded -->https://www.linkedin.com/pulse/q1-2017-noteworthy-young-life-sciences-startups-got-funded-bheda …
Thanks. Twitter will use this to make your timeline better. Undo -
Synthetic Biology + Therapeutics -->https://www.linkedin.com/pulse/synthetic-biology-therapeutics-pooja-bheda …
Thanks. Twitter will use this to make your timeline better. Undo -
16 Early-Stage Healthtech Startups You Need To Know -->https://www.linkedin.com/pulse/16-early-stage-healthtech-startups-you-need-know-pooja-bheda …
Thanks. Twitter will use this to make your timeline better. Undo -
Ready-to-Use Prefilled Syringes Available for Pain Managementhttp://bit.ly/2lzRrfE
Thanks. Twitter will use this to make your timeline better. Undo -
Thanks. Twitter will use this to make your timeline better. Undo
-
Immunomedics Enters into Exclusive Global Licensing Agreement with Seattle Geneticshttp://prn.to/2kOUfqK
Thanks. Twitter will use this to make your timeline better. Undo -
Oncoinvent Raises $25M | GEN Genetic Engineering & Biotechnology News - Biotech from Bench to Business | GEN http://bit.ly/2kP5LSX
Thanks. Twitter will use this to make your timeline better. Undo -
Eli Lilly to aquire CoLucid Pharmaceuticals for $960 millionhttp://bit.ly/2kMfR4O
Thanks. Twitter will use this to make your timeline better. Undo -
FDA Cites 22 Failed Trials in Report, Making the Case for the Phase III Gold Standardhttp://bit.ly/2kQY4Zv
Thanks. Twitter will use this to make your timeline better. Undo -
Calithera and Incyte Agree on $53M Up-Front Deal http://bit.ly/2kQGy7V
Thanks. Twitter will use this to make your timeline better. Undo -
Two New Breath-Activated Inhalers Gain FDA Approval for Asthmahttp://bit.ly/2jr3U7D
Thanks. Twitter will use this to make your timeline better. Undo -
Thanks. Twitter will use this to make your timeline better. Undo
-
Key trends from life science industry's largest conference -->https://www.linkedin.com/pulse/key-trends-from-life-science-industrys-largest-conference-pooja-bheda …
Thanks. Twitter will use this to make your timeline better. Undo -
Thanks. Twitter will use this to make your timeline better. Undo
-
Thanks. Twitter will use this to make your timeline better. Undo
-
SMC OKs four new therapies for NHS use in Scotland - PharmaTimes http://bit.ly/2jDFmXN
Thanks. Twitter will use this to make your timeline better. Undo
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.